Two Assistants, One Exam Room: Designing a Workflow Where Scribe Tools and Research Assistants Coexist

Clinicians rarely need just one kind of help. A busy hospitalist may want a reliable draft of the encounter note and a fast way to check the latest guideline on a complex medication question. A primary care team may need documentation support during annual wellness visits, while a pharmacist may need evidence retrieval for a vaccine or interaction question. Scribe tools and research assistants address different parts of that reality. The challenge is not choosing one over the other; it is arranging them so they support the same clinical workflow without adding noise, duplicating effort, or blurring accountability. AI can help with documentation and evidence retrieval, but it supports, and does not replace, clinical judgment. Every answer and every note still needs clinician review, and evidence-based answers should be verified against the cited sources.

Separate Jobs, Shared Goals: What Each Tool Does Best

A scribe tool is primarily a documentation aid. It may listen to the encounter, accept text input, or otherwise help capture the history, exam, assessment, and plan in a form that can be reviewed and edited before entering the EHR. Its value is in reducing administrative load and helping the clinician produce a faithful record. A research assistant, by contrast, is an evidence retrieval and decision-support aid. It responds to clinical questions—typed or spoken—with summaries and citations to source materials such as peer-reviewed journals and clinical guidelines. Its value is in shortening the path from a question to a verifiable source, not in writing the encounter note.

Because both tools can use natural language and both may sit near the EHR, teams sometimes treat them as interchangeable. That is a mistake. If a scribe tool is asked to answer a clinical question, it may lack the evidence-retrieval design and citation trail needed for verification. If a research assistant is asked to document an encounter, it may not capture the patient-specific narrative with the same fidelity as a documentation tool. The safer pattern is to define each tool’s lane. Scribes capture and draft the encounter. Research assistants answer focused clinical questions and point to evidence. Clinicians remain the decision-makers. When evaluating products, it helps to compare categories directly, such as the difference between an AI medical assistant vs AI medical scribe, so the team understands what each is designed to do and where the handoffs should occur.

This separation also matters for privacy. Scribe tools often process patient-specific encounter data. Research assistants may be used with clinical questions that include patient details, or they may be used with de-identified questions. Before either tool is used, the organization should be clear about what data each tool receives, what the vendor’s data-handling terms allow, and what local policy requires. Discussing HIPAA considerations generally, the minimum-necessary principle still applies: clinicians should avoid entering identifiable information into tools that are not authorized for that purpose. The roles are distinct, but the governance has to be shared.

Practical Workflow Patterns That Keep Both Tools in Their Lanes

The most workable workflows separate documentation from evidence retrieval by time and intent. Before a visit, a clinician or team member might use a research assistant to check a guideline or evidence summary relevant to the scheduled problem. During the visit, the scribe tool handles documentation while the clinician focuses on the patient. If a clinical question arises mid-encounter, the clinician can pause to use the research assistant for a narrow query, or note the question for a post-visit check. After the visit, the clinician reviews and edits the scribe draft, then uses the research assistant to verify any evidence that influenced the plan. This sequence keeps the scribe from becoming an unreliable answer engine and keeps the research assistant from becoming an unverified note generator.

For hospitalists, a practical pattern is to let the scribe tool support admission and rounding documentation, while the research assistant is used for targeted questions about guideline-concordant therapy, dosing references, or diagnostic evidence. For family physicians and primary care teams, the scribe can support chronic care and preventive visits, while the research assistant supports questions about screening intervals, vaccine recommendations, or medication safety. Pharmacists may lean more heavily on evidence retrieval and less on scribe documentation, but they can still contribute to the same workflow by checking drug-related questions and citing the sources used in team discussions. The common thread is that each tool is triggered by a different need: documentation burden versus evidence uncertainty.

EHR-centred design matters. When tools fit near the documentation and ordering workflow, clinicians are less likely to copy information between systems or lose the citation trail. Teams should ask practical questions: Where does the scribe draft appear for review? How are corrections made? Where does the research assistant’s answer and citation list live so it can be checked later? If a tool is not integrated, the team needs a safe, policy-compliant way to move only what is necessary. The goal is not maximal automation; it is a reviewable workflow in which the note and the evidence can both be audited. That is also where a tool such as ZoeMD may fit in body context—as a clinical decision support tool for healthcare professionals that answers natural-language questions with citations and links to source materials—but it should be used alongside, not instead of, documentation review and clinical judgment.

Governance, Verification, and Training for a Combined Workflow

Coexistence depends less on the software than on the habits around it. The first habit is verification. A research assistant’s answer is a starting point, not a final answer. Clinicians should open the cited guideline or journal article, check that the citation actually supports the statement, and consider whether the evidence applies to the patient in front of them. The second habit is review. A scribe’s draft is a draft; it must be edited for accuracy, context, and tone before it becomes the record. These habits protect against automation bias—the tendency to accept a fluent output because it looks complete. They also keep the clinician’s accountability visible to the team.

Governance should cover both tools in one policy rather than in separate silos. The policy can address which tools are approved, what patient information may be entered, how access is managed, how outputs are reviewed, and how questions about data handling are escalated. HIPAA considerations should be discussed generally and with the organization’s privacy or compliance team; no article can substitute for local legal and policy review. Training should include realistic scenarios: a hospitalist using a scribe during rounds and a research assistant for a guideline question; a primary care clinician using a scribe for a chronic care visit and a research assistant to check a screening recommendation; a pharmacist using evidence retrieval to support a medication review. Teams should practice the handoffs, including what to do when the research assistant’s answer conflicts with the scribe’s draft or with the clinician’s initial impression.

It also helps to assign clear ownership. One clinician or workflow lead can be responsible for reviewing tool outputs and gathering feedback. A pharmacist may own medication-related evidence checks. A primary care team may designate who reviews scribe drafts before sign-off. The point is not to create bureaucracy but to make the combined workflow predictable. When both tools are treated as assistants with defined jobs, the clinician can move between documentation and evidence retrieval without losing the thread of the encounter. AI can support the work, but the clinical judgment, the verification against cited sources, and the final sign-off remain human responsibilities.

By Anton Bogdanov

Novosibirsk-born data scientist living in Tbilisi for the wine and Wi-Fi. Anton’s specialties span predictive modeling, Georgian polyphonic singing, and sci-fi book dissections. He 3-D prints chess sets and rides a unicycle to coworking spaces—helmet mandatory.